TNDM
Tandem Diabetes Care, Inc.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Sell
-21/100
Last price
16.16
▼ 0.36 (2.18%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
16.45
Prev close
16.52
Day high
17.05
Day low
15.94
Volume
1.48M
Market cap
$1.12B
P/E (TTM)
—
52W range
12.26 – 29.65
Day trading desk
Gap from prior close
-0.42%
Prior close 16.52
VWAP
16.23
-0.46% from price
Relative volume
1.39×
Normal
Session range
20.00%
15.00 – 18.00
Position in range
39%
Mid range
ATR (14D)
1.01
6.24% of price
Prior day high
16.95
PDH
Prior day low
16.14
PDL
Bid / ask spread
—
Quote not published
Session volume
2.77M
Avg 1.99M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-2.47%
-4.4%
1M
-18.79%
-19.9%
3M
+6.60%
+2.1%
6M
-11.60%
-29.8%
YTD
-26.48%
-40.7%
1Y
+9.86%
-6.6%
3Y
-22.20%
-104.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on TNDM open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
814.07K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 14, 26 | HANSEN SHANNON MARIE Officer |
— | 3.01K | — | Direct |
| Aug 14, 26 | GASSER ELIZABETH ANNE Officer |
— | 3.01K | — | Direct |
| Aug 14, 26 | MORRISON SUSAN M Officer |
— | 2.83K | — | Direct |
| Aug 14, 26 | VOSSELLER LEIGH A Chief Financial Officer |
— | 4.12K | — | Direct |
| Aug 14, 26 | KYRILLOS JEAN-CLAUDE Chief Operating Officer |
— | 1.01K | — | Direct |
| Aug 14, 26 | SHERIDAN JOHN F Chief Executive Officer |
— | 15.92K | — | Direct |
| Aug 14, 26 | CARPENTER RICK Chief Technology Officer |
— | 2.51K | — | Direct |
| Jul 15, 26 | KYRILLOS JEAN-CLAUDE Chief Operating Officer |
— | 3.64K | — | Direct |
| Jun 2, 26 | GASSER ELIZABETH ANNE Officer |
STOCK | 7.16K | $0 | Direct |
| May 21, 26 | CHA MYOUNGIL Director |
— | 8.76K | — | Direct |
| May 21, 26 | MALAGUEIRA JOAO PAULO FALCAO Director |
— | 8.76K | — | Direct |
| May 21, 26 | SODHI RAJWANT Director |
— | 8.76K | — | Direct |
| May 21, 26 | MCGRODDY-GOETZ KATHLEEN Director |
— | 8.76K | — | Direct |
| May 21, 26 | ALLEN DICK P Retired |
— | 8.76K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ALLEN DICK P |
Retired | 50.90K | Conversion of Exercise of derivative security |
BLICKENSTAFF KIM D |
Director | — | Sale |
CARPENTER RICK |
Chief Technology Officer | 32.15K | Conversion of Exercise of derivative security |
GASSER ELIZABETH ANNE |
Officer | 34.51K | Conversion of Exercise of derivative security |
HANSEN SHANNON MARIE |
Officer | 33.59K | Conversion of Exercise of derivative security |
MORRISON SUSAN M |
Officer | 52.79K | Conversion of Exercise of derivative security |
NOVARA MARK DAVID |
Officer | 40.32K | Conversion of Exercise of derivative security |
SHERIDAN JOHN F |
Chief Executive Officer | 160.26K | Conversion of Exercise of derivative security |
TWOMEY CHRISTOPHER J |
Director | 37.11K | Conversion of Exercise of derivative security |
VOSSELLER LEIGH A |
Chief Financial Officer | 77.62K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$1.12B
Enterprise value$1.41B
Revenue (TTM)$1.04B
Gross profit$583.32M
EBITDA$-25.03M
Net income$-63.31M
EPS (TTM)$-0.89
Free cash flow$-43.95M
Total cash$456.00M
Total debt$739.25M
Book value / share$1.88
Shares outstanding69.58M
Float63.76M
Short % of float24.01%
Dividend yield0.00%
Beta (5Y)1.66
Valuation & profitability ratios
Trailing P/E—
Forward P/E94.67
PEG ratio—
Price / sales—
Price / book8.62
EV / revenue1.35
EV / EBITDA-56.23
Gross margin56.01%
Operating margin-5.42%
Profit margin-6.08%
Return on equity-48.03%
Return on assets-2.65%
Debt / equity566.96
Current ratio3.18
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.01B | $940.20M | $747.72M | $801.22M | +7.9% |
| Operating revenue | $1.01B | $940.20M | $747.72M | $801.22M | +7.9% |
| Cost of revenue | $468.72M | $450.63M | $380.03M | $388.23M | +4.0% |
| Gross profit | $546.01M | $489.57M | $367.69M | $412.99M | +11.5% |
| Research & development | $268.33M | $198.88M | $248.42M | $170.15M | +34.9% |
| Selling, general & admin | $444.99M | $389.82M | $352.50M | $335.68M | +14.2% |
| Total operating expense | $713.32M | $588.70M | $600.92M | $505.83M | +21.2% |
| Operating income | -$167.31M | -$99.13M | -$233.23M | -$92.85M | -68.8% |
| Net interest income | $1.18M | $10.58M | $12.98M | -$152.00K | -88.9% |
| Pre-tax income | -$200.27M | -$91.87M | -$220.25M | -$92.85M | -118.0% |
| Tax provision | $4.44M | $4.16M | $2.36M | $1.74M | +6.8% |
| Net income | -$204.71M | -$96.03M | -$222.61M | -$94.59M | -113.2% |
| Net income to common | -$204.71M | -$96.03M | -$222.61M | -$94.59M | -113.2% |
| Basic EPS | -3.04 | -1.47 | -3.43 | -1.47 | -106.8% |
| Diluted EPS | -3.04 | -1.47 | -3.43 | -1.47 | -106.8% |
| EBIT | -$194.22M | -$86.36M | -$212.18M | -$88.54M | -124.9% |
| EBITDA | -$176.56M | -$69.75M | -$196.46M | -$74.21M | -153.1% |
| Basic shares | 67.28M | 65.45M | 64.97M | 64.15M | +2.8% |
| Diluted shares | 67.28M | 65.45M | 64.97M | 64.15M | +2.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $90.63M | $69.23M | $58.87M | $172.52M | +30.9% |
| Cash & short-term investments | $292.67M | $438.33M | $467.91M | $616.90M | -33.2% |
| Accounts receivable | $165.49M | $114.58M | $105.56M | $114.72M | +44.4% |
| Inventory | $128.77M | $149.61M | $157.94M | $111.12M | -13.9% |
| Total current assets | $618.14M | $724.49M | $747.99M | $849.98M | -14.7% |
| Property, plant & equipment | $179.75M | $163.46M | $164.33M | $179.18M | +10.0% |
| Goodwill & intangibles | $11.72M | $925.00K | $2.78M | $4.63M | +1,167.0% |
| Total assets | $881.11M | $967.66M | $952.66M | $1.05B | -8.9% |
| Total current liabilities | $242.72M | $247.05M | $195.26M | $165.29M | -1.8% |
| Current debt | — | $40.67M | — | — | — |
| Long-term debt | $310.04M | $308.27M | $285.04M | $283.23M | +0.6% |
| Total debt | $444.48M | $473.56M | $415.67M | $419.88M | -6.1% |
| Total liabilities | $725.94M | $704.56M | $639.03M | $612.84M | +3.0% |
| Retained earnings | -$1.25B | -$1.05B | -$951.80M | -$729.19M | -19.5% |
| Shareholder equity | $155.17M | $263.10M | $313.63M | $439.95M | -41.0% |
| Working capital | $375.42M | $477.44M | $552.73M | $684.69M | -21.4% |
| Net tangible assets | $143.45M | $262.17M | $310.86M | $435.32M | -45.3% |
| Shares issued | 68.29M | 66.26M | 65.55M | 64.51M | +3.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$204.71M | -$96.03M | -$222.61M | -$94.59M | -113.2% |
| Depreciation & amortisation | $17.67M | $16.61M | $15.71M | $14.33M | +6.4% |
| Stock-based compensation | $92.38M | $101.38M | $88.08M | $84.92M | -8.9% |
| Change in working capital | -$23.04M | -$11.78M | -$17.68M | -$4.65M | -95.6% |
| Operating cash flow | -$9.72M | $24.23M | -$31.81M | $50.46M | -140.1% |
| Capital expenditure | -$98.54M | -$19.23M | -$96.30M | -$34.10M | -412.4% |
| Investing cash flow | $72.88M | -$23.48M | -$85.74M | $33.17M | +410.3% |
| Financing cash flow | -$43.37M | $8.37M | $4.11M | $16.88M | -618.3% |
| Free cash flow | -$108.26M | $4.99M | -$128.11M | $16.37M | -2,267.7% |
| End cash position | $90.63M | $69.23M | $58.87M | $172.52M | +30.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $254.56M | $247.22M | $290.38M | $249.25M | $240.68M | +3.0% |
| Operating revenue | $254.56M | $247.22M | $290.38M | $249.25M | $240.68M | +3.0% |
| Cost of revenue | $109.78M | $110.43M | $122.92M | $114.96M | $114.82M | -0.6% |
| Gross profit | $144.78M | $136.79M | $167.46M | $134.29M | $125.86M | +5.8% |
| Research & development | $46.93M | $46.03M | $46.07M | $48.72M | $48.12M | +1.9% |
| Selling, general & admin | $111.64M | $108.19M | $113.10M | $108.44M | $109.60M | +3.2% |
| Total operating expense | $158.57M | $154.22M | $159.17M | $157.16M | $157.71M | +2.8% |
| Operating income | -$13.79M | -$17.43M | $8.29M | -$22.86M | -$31.86M | +20.9% |
| Net interest income | -$1.23M | $1.42M | $941.00K | $444.00K | -$2.54M | -186.1% |
| Pre-tax income | -$20.66M | -$19.88M | $4.68M | -$25.14M | -$57.72M | -3.9% |
| Tax provision | $510.00K | $516.00K | $5.27M | -$3.98M | -$5.32M | -1.2% |
| Net income | -$21.17M | -$20.39M | -$589.00K | -$21.16M | -$52.40M | -3.8% |
| Net income to common | -$21.17M | -$20.39M | -$589.00K | -$21.16M | -$52.40M | -3.8% |
| Basic EPS | -0.31 | -0.30 | -0.01 | -0.31 | -0.78 | -3.3% |
| Diluted EPS | -0.31 | -0.30 | -0.01 | -0.31 | -0.78 | -3.3% |
| EBIT | -$18.21M | -$18.25M | $4.90M | -$23.08M | -$55.19M | +0.2% |
| EBITDA | -$13.74M | -$13.74M | $9.39M | -$18.59M | -$50.82M | +0.1% |
| Basic shares | 69.01M | 68.40M | 68.01M | 67.65M | 67.05M | +0.9% |
| Diluted shares | 69.01M | 68.40M | 68.01M | 67.65M | 67.05M | +0.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $62.82M | $179.32M | $90.63M | $91.95M | $64.11M | — | -65.0% |
| Cash & short-term investments | $456.00M | $570.26M | $292.67M | $319.11M | $315.36M | — | -20.0% |
| Accounts receivable | $162.06M | $140.67M | $165.49M | $125.94M | $128.44M | — | +15.2% |
| Inventory | $135.11M | $126.40M | $128.77M | $137.28M | $142.57M | — | +6.9% |
| Total current assets | $804.64M | $887.10M | $618.14M | $616.94M | $614.82M | — | -9.3% |
| Property, plant & equipment | $184.69M | $178.99M | $179.75M | $176.28M | $175.95M | — | +3.2% |
| Goodwill & intangibles | — | — | $11.72M | — | — | — | — |
| Total assets | $1.15B | $1.15B | $881.11M | $874.65M | $875.74M | — | +0.1% |
| Total current liabilities | $253.00M | $247.96M | $242.72M | $252.54M | $251.69M | — | +2.0% |
| Current debt | — | — | — | — | — | $40.74M | — |
| Long-term debt | $602.58M | $601.77M | $310.04M | $309.59M | $309.15M | — | +0.1% |
| Total debt | $739.25M | $734.74M | $444.48M | $449.28M | $449.01M | — | +0.6% |
| Total liabilities | $1.02B | $1.02B | $725.94M | $741.69M | $742.45M | — | +0.3% |
| Retained earnings | -$1.29B | -$1.27B | -$1.25B | -$1.25B | -$1.23B | — | -1.7% |
| Shareholder equity | $130.39M | $132.40M | $155.17M | $132.97M | $133.28M | — | -1.5% |
| Working capital | $551.63M | $639.14M | $375.42M | $364.40M | $363.13M | — | -13.7% |
| Net tangible assets | $130.39M | $132.40M | $143.45M | $132.97M | $133.28M | — | -1.5% |
| Shares issued | 69.54M | 68.50M | 68.29M | 67.77M | 67.53M | — | +1.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$21.17M | -$20.39M | -$589.00K | -$21.16M | -$52.40M | -3.8% |
| Depreciation & amortisation | $4.47M | $4.50M | $4.50M | $4.49M | $4.37M | -0.8% |
| Stock-based compensation | $15.74M | $15.66M | $20.11M | $21.14M | $25.64M | +0.5% |
| Change in working capital | -$41.50M | $3.68M | -$23.54M | -$2.85M | $9.16M | -1,228.9% |
| Operating cash flow | -$34.63M | $11.05M | $9.79M | $8.26M | -$9.50M | -413.3% |
| Capital expenditure | -$4.05M | -$6.27M | -$41.81M | -$4.09M | -$6.21M | +35.4% |
| Investing cash flow | -$87.34M | -$195.45M | -$14.98M | $20.54M | $58.13M | +55.3% |
| Financing cash flow | $2.15M | $274.16M | $2.60M | -$1.57M | -$39.71M | -99.2% |
| Free cash flow | -$38.68M | $4.79M | -$32.02M | $4.17M | -$15.70M | -908.2% |
| End cash position | $62.82M | $179.32M | $90.63M | $91.95M | $64.11M | -65.0% |
Options analytics
Put / call volume
0.16
Call-heavy session
Put / call open interest
1.65
Positioning, not flow
Max pain
16.00
-1.0% from spot
ATM implied vol
98.3%
Nearest strike to spot
Skew (10% OTM)
-81.2%
Calls bid over puts
Call volume
119
Contracts, this expiry
Put volume
19
Contracts, this expiry
Heaviest call OI
16.00
78 contracts
Heaviest put OI
15.00
135 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.32 | -0.31 | +2.8% |
| Mar 2026 | -0.44 | -0.30 | +32.2% |
| Dec 2025 | -0.09 | -0.01 | +88.9% |
| Sep 2025 | -0.34 | -0.31 | +8.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.24 | 19 | $265.85M | +6.7% |
| Next quarter | 0.18 | 19 | $304.37M | +4.8% |
| Current year | -0.67 | 20 | $1.07B | +5.7% |
| Next year | 0.17 | 20 | $1.20B | +12.4% |
Analyst targets & ownership
Mean target$28.35
High target$50.00
Low target$18.00
Implied upside75.43%
Analyst count20
ConsensusBUY
Strong buy / Buy3 / 11
Hold10
Sell / Strong sell0 / 0
Held by insiders1.17%
Held by institutions115.89%
Institutions holding373
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
16.23
-0.43% from price
SMA 20
16.83
-4.00% from price
SMA 50
19.49
-17.09% from price
SMA 100
17.80
-9.22% from price
SMA 200
19.38
-16.62% from price
EMA 12
16.63
-2.82% from price
EMA 26
17.52
-7.78% from price
EMA 50
18.17
-11.06% from price
RSI (14)
38.1
Neutral
MACD (12,26,9)
-0.89
Hist 0.07
ATR (14)
1.01
6.24% of price
Realised vol 30D
52.2%
Annualised
Bollinger upper
18.55
20, 2σ
Bollinger lower
15.11
20, 2σ
50 / 200 cross
Golden
19.49 vs 19.38
Trend bias
Below 200
-16.62%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.01
More volatile than market
Correlation to SPY
0.17
Largely independent
Realised vol 30D
52.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-54.6%
Peak to trough
Max drawdown 5Y
-93.4%
Peak to trough
ATR 14
1.01
6.24% of price
Beta (reported)
1.66
5Y monthly, from filing
Short interest
Shares short
12.47M
Prior 10.59M
Change vs prior
+17.8%
Shorts adding
% of float
24.01%
Heavily shorted
% of shares out
17.93%
Against total outstanding
Days to cover
8.1
Crowded exit
Float
63.76M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 30, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Sep 24, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Aug 21, 26 | William Blair | INITIATED | — | Outperform |
| Aug 7, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Aug 7, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 15, 26 | Mizuho | MAINTAINED | Neutral | Neutral |
| Jun 23, 26 | Deutsche Bank | INITIATED | Buy | Hold |
| Jun 1, 26 | Wells Fargo | UPGRADE | Equal-Weight | Overweight |
| May 28, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| May 18, 26 | B of A Securities | MAINTAINED | Neutral | Neutral |
| May 12, 26 | Benchmark | INITIATED | — | Hold |
| May 11, 26 | Truist Securities | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay dateOct 10, 2017
Last split1:10
Split dateOct 10, 2017
SEC filings
Periodic Financial Reports
10-Q · 2026-08-06
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-28
Offering Registrations
S-8 · 2026-05-27
Corporate Changes & Voting Matters
8-K · 2026-05-21
Corporate Changes & Voting Matters
8-K · 2026-05-15
Periodic Financial Reports
10-Q · 2026-05-07
Annual Report to Shareholders
ARS · 2026-04-08
Proxy Statements
DEF 14A · 2026-04-07
Headlines
Tandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026
Business Wire · 5d ago
Tandem Diabetes Care (TNDM) Is Up 7.2% After International Launch Of Mobi Insulin Pump System
Simply Wall St. · 6d ago
Q2 Earnings Highlights: Tandem Diabetes (NASDAQ:TNDM) Vs The Rest Of The Healthcare Technology Stocks
StockStory · 6d ago
Sector Update: Healthcare Stocks Lean Lower Premarket Monday
MT Newswires · 9d ago
Tandem Diabetes Expands Insulin Delivery System to 12 New Countries
MT Newswires · 9d ago
Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets
Business Wire · 9d ago
Truist Lowers Price Target on Tandem Diabetes Care to $28 From $31, Keeps Buy Rating
MT Newswires · 13d ago
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know
StockStory · 13d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.